Int J Med Sci 2013; 10(12):1625-1631. doi:10.7150/ijms.6824 This issue Cite

Research Paper

Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study

Jiajia Chen, Qing Yang, Jianrong Huang, Lanjuan Li1, 2,✉

1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
2. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China

Citation:
Chen J, Yang Q, Huang J, Li L. Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study. Int J Med Sci 2013; 10(12):1625-1631. doi:10.7150/ijms.6824. https://www.medsci.org/v10p1625.htm
Other styles

File import instruction

Abstract

Background: Invasive pulmonary aspergillosis (IPA) in acute-on-chronic liver failure (ACLF) patients is associated with a high mortality. But the clinical characteristics of and the risk factors for IPA among patients with ACLF remains unclear. This study was aimed at assessing clinical manifestation, the risk factors and antifungal medications for as well as the mortality due to IPA in ACLF patients at the First Affiliated Hospital, College of Medicine, Zhejiang University.

Patients and Methods: Patients with ACLF who were diagnosed with proven or probable IPA by clinical and laboratory parameters from 1 December 2008 to 1 May 2012 were retrospectively evaluated to determine the risk factors for IPA and the clinical outcomes. The follow-up ended on 30 July 2012. Multivariate analysis was performed to identify the risk factors for mortality and the development of IPA.

Results: In total, 787 patients with ACLF were enrolled, and 39 of these patients developed IPA. Thirty seven of these 39 patients died in spite of treatment with antifungal drugs. Controls included 48 patients who did not have a pulmonary infection. The survival rate of patients with IPA was significantly lower than that of those without IPA. IPA was found to be independently associated with age (p = 0.021), encephalopathy (p = 0.002), and steroid use (p = 0.000). There was significant difference in the prognosis between the patients treated with either voriconazole or itraconazole and those without antifungal treatment.

Conclusions: Patients with ACLF and IPA have a high mortality rate. Patients with ACLF who present with encephalopathy should avoid steroids, as they increase the mortality rate. Azoles may prolong the survival time.

Keywords: Liver failure, Invasive pulmonary aspergillosis, Antifungal agents


Citation styles

APA
Chen, J., Yang, Q., Huang, J., Li, L. (2013). Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study. International Journal of Medical Sciences, 10(12), 1625-1631. https://doi.org/10.7150/ijms.6824.

ACS
Chen, J.; Yang, Q.; Huang, J.; Li, L. Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study. Int. J. Med. Sci. 2013, 10 (12), 1625-1631. DOI: 10.7150/ijms.6824.

NLM
Chen J, Yang Q, Huang J, Li L. Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study. Int J Med Sci 2013; 10(12):1625-1631. doi:10.7150/ijms.6824. https://www.medsci.org/v10p1625.htm

CSE
Chen J, Yang Q, Huang J, Li L. 2013. Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study. Int J Med Sci. 10(12):1625-1631.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image